Search Results 401-410 of 17367 for alopecia

1. Triamcinolone (topical application route) - Mayo Clinic

   Triamcinolone topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. This medicine is a corticosteroid ( ...

2. What is aspirin-exacerbated respiratory disease (AERD)? - Mayo Clinic

   AERD, also called Samter's triad, has three features: asthma, recurring nasal polyps, and sensitivity to aspirin and drugs such as ibuprofen and naproxen.

3. A Study to Evaluate the Effectiveness and Safety of bb2121 in Subjects with Relapsed and Refractory Multiple Myeloma and in Subjects with Clinical High-Risk Multiple Myeloma - Mayo Clinic

   due to prior treatments, excluding alopecia and Grade 2 neuropathy. Exclusion Criteria: The presence of any of the following will exclude a subject from ...

4. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

   ... alopecia, or peripheral neuropathy up to grade 2 - Any major surgery =< 4 weeks prior to registration - Any serious and/or unstable pre-existing medical ...

5. Halcinonide (topical application route) - Mayo Clinic

   Halcinonide topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. This medicine is a corticosteroid ( ...

6. Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

   Significant autoimmune disease with the exception of alopecia, vitiligo, hypothyroidism or other conditions that have never been clinically active or were ...

7. Phase I Study of LB-100 With Docetaxel in Solid Tumors - Mayo Clinic

   Patients must have recovered from all acute adverse effects (excluding alopecia) of prior therapies to baseline or ≤ grade 1 prior to study entry. Patients ...

8. Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202) - Mayo Clinic

   Complete resolution of toxic effect(s) of the most recent prior chemotherapy to Grade 1 or less (except alopecia). If the subject received major surgery or ...

9. A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer - Mayo Clinic

   Grade > 1 alopecia or fatigue is permitted. Participants must allow a ... alopecia) not requiring systemic treatment, or conditions not expected to ...

10. Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment - Mayo Clinic

    - Patients who have not recovered from adverse events due to prior anti-cancer therapy (i.e., have residual toxicities > grade 1) with the exception of alopecia ...